Bill Text: TX HR77 | 2023-2024 | 88th Legislature | Enrolled
Bill Title: Recognizing February 22, 2023, as Hypertrophic Cardiomyopathy Awareness Day.
Sponsorship: Bipartisan Bill
Status: (Passed) 2023-02-22 - Reported enrolled [HR77 Detail]
Download: Texas-2023-HR77-Enrolled.html
| H.R. No. 77 | ||
|
|
||
| WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking | ||
| place on February 22, 2023, and this occasion provides a fitting | ||
| opportunity to promote better understanding of this health issue; | ||
| and | ||
| WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic | ||
| cardiovascular disease that involves thickening of the heart muscle | ||
| and can potentially lead to debilitating symptoms and serious | ||
| complications, including heart failure, atrial fibrillation, | ||
| stroke, and in rare cases, sudden cardiac death; and | ||
| WHEREAS, HCM is the most common inheritable heart disease; it | ||
| can affect anyone, regardless of age, gender, or ethnicity, and it | ||
| has a reported prevalence ranging from 1 in 200 individuals to 1 in | ||
| 500 individuals in the general population; an estimated 58,722 to | ||
| 146,804 people in Texas have HCM, although approximately 85 percent | ||
| of them remain undiagnosed; and | ||
| WHEREAS, HCM shares symptoms with other common | ||
| cardiovascular and pulmonary diseases, such as shortness of breath, | ||
| chest pain, fatigue, palpitations, and fainting, and those | ||
| similarities make it difficult to accurately diagnose HCM; in | ||
| addition, the all-cause mortality risk is three to four times | ||
| higher in patients with HCM than that of the general population; in | ||
| order to receive a diagnosis, patients should know their medical | ||
| history and stay informed about the signs and symptoms of HCM; and | ||
| WHEREAS, Health care providers must conduct thorough | ||
| screenings with cardiac health questions to help identify a risk of | ||
| both genetic and congenital cardiac disorders; they may also | ||
| conduct several tests, including an echocardiogram, a cardiac MRI, | ||
| or genetic testing to confirm a family history of HCM, and they must | ||
| examine the heart to diagnose HCM; and | ||
| WHEREAS, Following a diagnosis of HCM, it is important for | ||
| patients to work with their health care providers to learn more | ||
| about the disease and different management options, such as | ||
| prescription medicines and surgical treatments; and | ||
| WHEREAS, Hypertrophic cardiomyopathy is a serious and | ||
| life-threatening disease, and the observance of Hypertrophic | ||
| Cardiomyopathy Awareness Day unites people around the world in | ||
| their commitment to improving the quality of life for patients; | ||
| now, therefore, be it | ||
| RESOLVED, That the House of Representatives of the 88th Texas | ||
| Legislature hereby recognize February 22, 2023, as Hypertrophic | ||
| Cardiomyopathy Awareness Day and urge all Texans to learn more | ||
| about the disease; and, be it further | ||
| RESOLVED, That an official copy of this resolution be | ||
| prepared for the Hypertrophic Cardiomyopathy Association as an | ||
| expression of high regard by the Texas House of Representatives. | ||
| Lalani | ||
| ______________________________ | ||
| Speaker of the House | ||
| I certify that H.R. No. 77 was adopted by the House on | ||
| February 22, 2023, by a non-record vote. | ||
| ______________________________ | ||
| Chief Clerk of the House | ||
